Tada T - Search Results

1

Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.

Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Yokohama K, Nishikawa H, Nishimura T, Shimada N, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Aoki T, Tanaka K, Tanaka T, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kudo M, Kumada T; Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hatanaka T, et al. Among authors: tada f, tada t. Hepatol Res. 2024 Apr;54(4):382-391. doi: 10.1111/hepr.13991. Epub 2023 Dec 6. Hepatol Res. 2024. PMID: 37983642

2

Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.

Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S. Tada T, et al. Liver Int. 2005 Aug;25(4):848-53. doi: 10.1111/j.1478-3231.2005.01111.x. Liver Int. 2005. PMID: 15998436

3

Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Takagi M, Hiramatsu T, Hosokawa T, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: tada t. J Clin Virol. 2010 Mar;47(3):258-62. doi: 10.1016/j.jcv.2009.12.023. Epub 2010 Jan 29. J Clin Virol. 2010. PMID: 20116330

4

Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load.

Toyoda H, Kumada T, Tada T, Arakawa T, Hayashi K, Honda T, Katano Y, Goto H. Toyoda H, et al. Among authors: tada t. J Gastroenterol Hepatol. 2010 Jun;25(6):1072-8. doi: 10.1111/j.1440-1746.2010.06240.x. J Gastroenterol Hepatol. 2010. PMID: 20594221

5

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Takagi M, Hiramatsu T, Hosokawa T, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: tada t. J Med Virol. 2010 Sep;82(9):1537-44. doi: 10.1002/jmv.21858. J Med Virol. 2010. PMID: 20648607

6

Outcome in partial early virologic responders to combination therapy with peginterferon and ribavirin in patients infected with hepatitis C virus genotype 1b.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Hosokawa T, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: tada t. J Med Virol. 2011 Jan;83(1):101-7. doi: 10.1002/jmv.21936. J Med Virol. 2011. PMID: 21108345

7

Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.

Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Tanaka J, Yoshizawa H. Kumada T, et al. Among authors: tada t. J Gastroenterol. 2011 Apr;46(4):536-44. doi: 10.1007/s00535-010-0349-7. Epub 2010 Dec 7. J Gastroenterol. 2011. PMID: 21132575

8

Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.

Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, Satomura S. Toyoda H, et al. Among authors: tada t. Cancer Sci. 2011 May;102(5):1025-31. doi: 10.1111/j.1349-7006.2011.01875.x. Epub 2011 Feb 28. Cancer Sci. 2011. PMID: 21244578 Free article.

9

Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.

Kudo M, Hatanaka K, Kumada T, Toyoda H, Tada T. Kudo M, et al. Among authors: tada t. Am J Gastroenterol. 2011 Feb;106(2):368-70. doi: 10.1038/ajg.2010.432. Am J Gastroenterol. 2011. PMID: 21301463 No abstract available.

10

Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C.

Toyoda H, Kumada T, Tada T, Kawaguchi T, Murakami Y, Matsuda F. Toyoda H, et al. Among authors: tada t. J Med Virol. 2011 Jul;83(7):1203-11. doi: 10.1002/jmv.22092. J Med Virol. 2011. PMID: 21567424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,703 results

Search Page

Filters